C. Lance Cowey

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX

Presentation(s):

• SP05A - Outcomes in Patients (pts) with Advanced Basal Cell Carcinoma (aBCC) Who Discontinued First-line (1L) Hedgehog Inhibitors (HHI) Systemic Treatment (Tx) in a US Community Oncology Setting: A Retrospective Observational Study

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time